Shanghai Pharmaceuticals, China’s largest drug distributor, will launch a China healthcare venture capital investment fund that will ultimately raise $470 million. The first tranche will be $157 million and Shanghai Pharma will contribute 25% of that, or just under $40 million. The VC fund will back healthcare start-ups in all life science fields. The news came from a securities filing.
Help employers find you! Check out all the jobs and post your resume.
